Catalent
CTLT
#1573
Rank
NZ$18.35 B
Marketcap
$101.11
Share price
0.74%
Change (1 day)
70.88%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$16.54 Billion

According to Catalent's latest financial reports the company's total assets are NZ$16.54 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30NZ$17.76 B5.24%
2022-06-30NZ$16.88 B29.49%
2021-06-30NZ$13.03 B7.74%
2020-06-30NZ$12.09 B31.52%
2019-06-30NZ$9.19 B37.5%
2018-06-30NZ$6.69 B41.58%
2017-06-30NZ$4.72 B8.91%
2016-06-30NZ$4.33 B-5.44%
2015-06-30NZ$4.58 B30.32%
2014-06-30NZ$3.52 B-7.55%
2013-06-30NZ$3.80 B-2.62%
2012-06-30NZ$3.91 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$2.28 B-86.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.63 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.88 B 26.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$0.66 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA